Literature DB >> 24838619

Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer.

Chun Huang1, Xuan Wang, Baocun Sun, Man Li, Xiulan Zhao, Yanjun Gu, Yanfen Cui, Yan Li.   

Abstract

To investigate the association between high parity and triple-negative breast cancer (TNBC), and explore the etiologic mechanisms of TNBC in Tientsin Albinao 2 (TA2) mice model. After the TA2 mice model with high parity and TNBC had been established, the cell proliferation and apoptosis were detected by immunohistochemical and TUNEL staining in mammary epithelia from different conditions, which included non-pregnancy, low and high gravidity in pregnancy, and carcinogenesis. Apoptotic signaling was analyzed by measuring bcl-2, bax, caspase-3, and caspase-9 expression using immunohistochemistry (IHC), western blot, and real-time PCR technique. Estrogen receptor α (ERα) and progesterone receptor (PR) were determined by immunohistochemical staining and real-time PCR. Both proliferation and apoptosis in mammary epithelia changed with the increasing of parity. Immunohistochemistry revealed increased cell proliferation and apoptosis were related with upregulation of ERα, PR, bcl-2, bax, caspase-3, and caspase-9 expression, especially during the fourth pregnancy. Mammary gland in the fourth pregnancy stage was the closest to precancerous. In precancerous mammary gland, cell proliferation rate was much higher than apoptosis rate. High parity could increase the ovarian hormones level and alter ovarian hormone receptor levels in TA2 mice, and their sensitivity to ovarian hormones result in the imbalance between cell proliferation and apoptosis in precancerous mammary epithelial cells.

Entities:  

Mesh:

Year:  2014        PMID: 24838619     DOI: 10.1007/s11523-014-0316-y

Source DB:  PubMed          Journal:  Target Oncol        ISSN: 1776-2596            Impact factor:   4.493


  33 in total

1.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c.

Authors:  T Rossé; R Olivier; L Monney; M Rager; S Conus; I Fellay; B Jansen; C Borner
Journal:  Nature       Date:  1998-01-29       Impact factor: 49.962

2.  Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.

Authors:  H Olsson; H Jernström; P Alm; H Kreipe; C Ingvar; P E Jönsson; S Rydén
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan.

Authors:  J S Lawson; A S Field; S Champion; D Tran; H Ishikura; D Trichopoulos
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

4.  The effect of high gravidity on the carcinogenesis of mammary gland in TA2 mice.

Authors:  Xuan Wang; Chun Huang; Baocun Sun; Yanjun Gu; Yanfen Cui; Xiulan Zhao; Yan Li; Shiwu Zhang
Journal:  Am J Reprod Immunol       Date:  2010-02-08       Impact factor: 3.886

5.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.

Authors:  Edgar S Díaz-Cruz; Priscilla A Furth
Journal:  Cancer Res       Date:  2010-05-15       Impact factor: 12.701

Review 7.  Human breast cell proliferation and its relationship to steroid receptor expression.

Authors:  R B Clarke
Journal:  Climacteric       Date:  2004-06       Impact factor: 3.005

8.  Dual effect of parity on breast cancer risk in African-American women.

Authors:  Julie R Palmer; Lauren A Wise; Nicholas J Horton; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

Review 9.  Toward a physiological approach to breast cancer prevention.

Authors:  J Russo; I H Russo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-06       Impact factor: 4.254

10.  Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Authors:  Julie Lecarpentier; Catherine Noguès; Emmanuelle Mouret-Fourme; Marion Gauthier-Villars; Christine Lasset; Jean-Pierre Fricker; Olivier Caron; Dominique Stoppa-Lyonnet; Pascaline Berthet; Laurence Faivre; Valérie Bonadona; Bruno Buecher; Isabelle Coupier; Laurence Gladieff; Paul Gesta; François Eisinger; Marc Frénay; Elisabeth Luporsi; Alain Lortholary; Chrystelle Colas; Catherine Dugast; Michel Longy; Pascal Pujol; Julie Tinat; Rosette Lidereau; Nadine Andrieu
Journal:  Breast Cancer Res       Date:  2012-07-03       Impact factor: 6.466

View more
  2 in total

1.  Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.

Authors:  Jayeon Kim; Volkan Turan; Kutluk Oktay
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

2.  Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues.

Authors:  So Yun Park; Kyungah Jeong; Eun Hye Cho; Hye Won Chung
Journal:  Clin Exp Reprod Med       Date:  2020-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.